Top cited articles
Acceptance rate:
9%
Time to first decision with review:
41 days*
Time from acceptance to publication:
24 days*
Impact Factor(JCR):
8.8
Citescore:
15.7
Total content views:
1.25 million
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease
Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension
Endovascular treatment for large-core ischaemic stroke: a meta-analysis of randomised controlled clinical trials
Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort
Nitrous oxide-induced myeloneuropathy: a case series
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
Functional neurological disorder is a feminist issue
Structural and functional changes in the retina in Parkinson's disease
Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson's disease
Predictors of persistent postural-perceptual dizziness (PPPD) and similar forms of chronic dizziness precipitated by peripheral vestibular disorders: a systematic review
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort
Epigenetic clocks in neurodegenerative diseases: a systematic review
Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assay
UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria